Skip to main content
SpringerLink
Log in

Community-based screening for HBV cost effective in Gambia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2013 US dollars

References

  1. Nayagam S, et al. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis. The Lancet Global Health 4: e568-e578, No. 8, Aug 2016. Available from: URL: http://dx.doi.org/10.1016/S2214-109X(16)30101-2

    Article  PubMed  Google Scholar 

  2. Allain J-P. Screen-and-treat for chronic hepatitis B: an overdue issue for sub-Saharan Africa. The Lancet Global Health 4: e507-e508, No. 8, Aug 2016. Available from: URL: http://dx.doi.org/10.1016/S2214-109X(16)30140-1

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Community-based screening for HBV cost effective in Gambia. PharmacoEcon Outcomes News 758, 17 (2016). https://doi.org/10.1007/s40274-016-3246-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3246-3

Search

Navigation